Keiichi Fujiwara, MD, PhD
Keiichi Fujiwara, MD, PhD
Chairman of the Department of Gynecologic Oncology
Saitama Medical University International Medical Center
Division of Gynecologic Oncology
1397-1 Yamane
Hidaka
Hidaka-Shi
Japan
350-1298
Papers:
4 - Seminal Abstract
A phase III, randomized, double-blind trialof weekly paclitaxel plus the angiopoientin 1 and 2 inhibitor, trebananib, or placebo in women with recurrent ovarian cancer: TRINOVA-1
138 - Scientific Plenary
Health-related quality-of-life analysis from the TRINOVA-1 study of weekly paclitaxel plus trebananib or placebo in women with recurrent ovarian cancer